Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE10A | Q9Y233 | 3/20 | 0.73 |
| ▸ | RXFP3 | Q9NSD7 | 7/20 | 0.42 |
| ▸ | PDE4A | P27815 | 3/20 | 0.41 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.41 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.41 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.41 |
| ▸ | GRM5 | P41594 | 2/20 | 0.41 |
| ▸ | HCRTR1 | O43613 | 3/20 | 0.41 |
| ▸ | HCRTR2 | O43614 | 3/20 | 0.41 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.36 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2563219 | 0.91 | PDE10A (0.63) | PDE10ARXFP3PDE4APDE4BPDE4C | |
| SCHEMBL2577947 | 0.86 | PDE10A (0.79) | PDE10APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL8272028 | 0.84 | PDE10A (0.75) | PDE10APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL7709752 | 0.84 | PDE10A (1.00) | PDE10APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL8271910 | 0.84 | PDE10A (0.73) | PDE10APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL7709755 | 0.84 | PDE10A (0.73) | PDE10APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL2578430 | 0.83 | PDE10A (0.73) | PDE10APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL7711525 | 0.83 | PDE10A (0.78) | PDE10ARXFP3PDE4APDE4BPDE4C | |
| SCHEMBL8271482 | 0.82 | PDE10A (0.71) | PDE10APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL2560664 | 0.81 | PDE10A (0.70) | PDE10APDE4APDE4BPDE4CPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011132051-A2 | TRICYCLE COMPOUNDS AS PHOSPHODIESTERASE-10 INHIBITORS | GLENMARK PHARMACEUTICALS S.A. (CH) | 2011-10-27 | — | — | WO | disclosed |